Name:  [**Known lastname 15309**], [**Known firstname 1495**]                   Unit No:  [**Numeric Identifier 15310**]  Admission Date:  [**2198-8-22**]     Discharge Date:  [**2198-8-30**]  Date of Birth:   [**2122-10-7**]     Sex:  M  Service:  CCU  ADDENDUM:  Mr. [**Known lastname 15311**] Foley catheter was discontinued on [**8-26**], but since he did not void for the next eight hours and complained of severe abdominal discomfort as well as penile pain, the Foley catheter was reinserted at 11:00 p.m. that night.
In light of his urinary retention of unknown etiology, his Foley catheter is to remain in place upon discharge.
Similarly, a scrotal ultrasound was performed the same date and showed a left varicocele, right hydrocele and multiple testicular as well as epididymal cysts.
He was continued on his cardiac medications except his ACE inhibitor in light of his mild renal insufficiency.
He was also continued on his diabetic medications and as a result, his blood sugars remained well controlled.
His Levaquin was discontinued on [**8-29**], after a full week course, for his presumed urinary tract infection.
Acute inferior lateral myocardial infarction status post stent of diagonal.
Coronary artery disease status post two myocardial infarctions ([**2192**] and [**2198**]).
Hematuria of unknown etiology, status post bladder irrigation.
Aspirin 325 mg p.o.
Plavix 75 mg p.o.
Protonix 40 mg p.o.
Synthroid 75 micrograms p.o.
Lipitor 20 mg p.o.
Paxil 20 mg p.o.
Colace 100 mg p.o.
Heparin 5000 units subcutaneously twice a day.
Metoprolol 50 mg p.o.
Hydralazine 10 mg p.o.
Glipizide 2.5 mg p.o.
The patient is to resume the medications listed above.
He is to have O2 nasal cannula at the rehabilitation center as needed to keep his saturations above 92%.
He is to continue his Foley catheter to gravity.
